Initial results of two phase I trials delivering mbIL-21 ex vivo expanded haploidentical NK cells after fludarabine/cytarabine for patients with relapsed/refractory myeloid leukemias.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.7008
Abstract: 7008Background: NK cells play an important role in the control of malignancies but are ablated by high-dose chemotherapy. Thus, rapid recovery of NK cell number and function correlates with improve... read more here.
Keywords: initial results; trials delivering; delivering mbil; two phase ... See more keywords